AI summarized from verified sources
Claude becomes easier to use for life sciences work
Expand Claude’s use across research and drug discovery.
SOURCE CHECK
4 sources
Sources
Key Points
- 1Dedicated program for life sciences
- 2Works with Mythos, Opus, and Sonnet
- 3Built for research, drug discovery, and clinical development
- 4Beta starts with teams and institutions
Anthropic launched the Life Sciences Verification Program, giving life science professionals access to Mythos, Opus, and Sonnet with more permissive biology safeguards. It expands use across research, drug discovery, clinical development, and manufacturing.
What happened
Anthropic introduced the Life Sciences Verification Program. It gives life science professionals access to its models with safety settings tuned to be more usable for biology-related work. Existing early access users are already onboarded, and broader applications are now open.
Why it matters
Research and drug discovery need both strong capability and safety. This program opens a path to use Claude for tasks that were more likely to be blocked, while keeping the scope controlled.
Impact for users
Teams and institutions can use Claude across Claude Science, Claude.ai, Claude Code, and the API. Anthropic also says it plans to expand access to individual Pro and Max plans over time.
Briefs that include this news
Use daily, weekly, and monthly briefs to understand the surrounding context.
Daily / 2026-09-20
Anthropic and OpenAI updates move AI forward on both use cases and manageability
Weekly / 2026-09-14 to 2026-09-20
Weekly roundup: AI use cases expanded, while management and safety improvements advanced
Monthly / 2026-09-01 to 2026-09-30
September 2026 AI news roundup: the focus shifts from performance to operations